Citations

Citations to this article as recorded by  

• Efficacy and safety of novel thiazolidinedione lobeglitazone for managing type-2 diabetes a meta-analysis
  Deep Dutta, Saptarshi Bhattacharya, Manoj Kumar, Priyankar K. Datta, Ritin Mohindra, Meha Sharma
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(1): 102697.     CrossRef
• Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis
  Shashank R. Joshi, Saibal Das, Suja Xaviar, Shambo Samrat Samajdar, Indranil Saha, Sougata Sarkar, Shatavisa Mukherjee, Santanu Kumar Tripathi, Jyotirmoy Pal, Nandini Chatterjee
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(1): 102703.     CrossRef
• The benefits of adipocyte metabolism in bone health and regeneration
  Lisa-Marie Burkhardt, Christian H. Bucher, Julia Löffler, Charlotte Rinne, Georg N. Duda, Sven Geissler, Tim J. Schulz, Katharina Schmidt-Bleek
  Frontiers in Cell and Developmental Biology.2023;[Epub]     CrossRef
• Will lobeglitazone rival pioglitazone? A systematic review and critical appraisal
  Kalyan Kumar Gangopadhyay, Awadhesh Kumar Singh
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(4): 102747.     CrossRef
• Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study
  Jun Hwa Hong, Jun Sung Moon, Kayeon Seong, Soo Lim
  Diabetes Research and Clinical Practice.2023; 203: 110872.     CrossRef
• Bone Mineral Density Evaluation Among Type 2 Diabetic Patients in Rural Haryana, India: An Analytical Cross-Sectional Study
  Nitish Khandelwal, Surbhi Rajauria, Siddhesh Pandurang Kanjalkar, Omkar Shivaji Chavanke, Sanjay Rai
  Cureus.2023;[Epub]     CrossRef
• Lobeglitazone and Its Therapeutic Benefits: A Review
  Balamurugan M, Sarumathy S, Robinson R
  Cureus.2023;[Epub]     CrossRef
• A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study
  Soree Ryang, Sang Soo Kim, Ji Cheol Bae, Ji Min Han, Su Kyoung Kwon, Young Il Kim, Il Seong Nam‐Goong, Eun Sook Kim, Mi‐kyung Kim, Chang Won Lee, Soyeon Yoo, Gwanpyo Koh, Min Jeong Kwon, Jeong Hyun Park, In Joo Kim
  Diabetes, Obesity and Metabolism.2022; 24(9): 1800.     CrossRef
• A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus
  Bo-Yeon Kim, Hyuk-Sang Kwon, Suk Kyeong Kim, Jung-Hyun Noh, Cheol-Young Park, Hyeong-Kyu Park, Kee-Ho Song, Jong Chul Won, Jae Myung Yu, Mi Young Lee, Jae Hyuk Lee, Soo Lim, Sung Wan Chun, In-Kyung Jeong, Choon Hee Chung, Seung Jin Han, Hee-Seok Kim, Ju-Y
  Diabetes & Metabolism Journal.2022; 46(6): 855.     CrossRef
• Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
  Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
  Diabetes Therapy.2021; 12(1): 171.     CrossRef
• Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
  Jaehyun Bae, Taegyun Park, Hyeyoung Kim, Minyoung Lee, Bong-Soo Cha
  Diabetes & Metabolism Journal.2021; 45(3): 326.     CrossRef
• Effect of lobeglitazone on motor function in rat model of Parkinson’s disease with diabetes co-morbidity
  Kambiz Hassanzadeh, Arman Rahimmi, Mohammad Raman Moloudi, Rita Maccarone, Massimo Corbo, Esmael Izadpanah, Marco Feligioni
  Brain Research Bulletin.2021; 173: 184.     CrossRef
• Recent Perspective on Thiazolidinedione
  Won Jun Kim
  The Journal of Korean Diabetes.2021; 22(2): 97.     CrossRef
• Use of in vitro bone models to screen for altered bone metabolism, osteopathies, and fracture healing: challenges of complex models
  Sabrina Ehnert, Helen Rinderknecht, Romina H. Aspera-Werz, Victor Häussling, Andreas K. Nussler
  Archives of Toxicology.2020; 94(12): 3937.     CrossRef
• Update on: effects of anti-diabetic drugs on bone metabolism
  Guillaume Mabilleau, Béatrice Bouvard
  Expert Review of Endocrinology & Metabolism.2020; 15(6): 415.     CrossRef
• The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta‐analysis of observational studies
  Khemayanto Hidayat, Xuan Du, Meng‐Jiao Wu, Bi‐Min Shi
  Obesity Reviews.2019; 20(10): 1494.     CrossRef
• Diabetes pharmacotherapy and effects on the musculoskeletal system
  Evangelia Kalaitzoglou, John L. Fowlkes, Iuliana Popescu, Kathryn M. Thrailkill
  Diabetes/Metabolism Research and Reviews.2019;[Epub]     CrossRef
• Morin Exerts Anti‐Arthritic Effects by Attenuating Synovial Angiogenesis via Activation of Peroxisome Proliferator Activated Receptor‐γ
  Mengfan Yue, Ni Zeng, Yufeng Xia, Zhifeng Wei, Yue Dai
  Molecular Nutrition & Food Research.2018;[Epub]     CrossRef
• The effects of diabetes therapy on bone: A clinical perspective
  Karim G. Kheniser, Carmen M. Polanco Santos, Sangeeta R. Kashyap
  Journal of Diabetes and its Complications.2018; 32(7): 713.     CrossRef
• Changes in the Bone Mineral Density of Femur Neck and Total Hip Over a 52-Week Treatment with Lobeglitazone
  Da Young Lee, Ji A Seo
  Diabetes & Metabolism Journal.2017; 41(5): 374.     CrossRef

Citations

Citations to this article as recorded by  

• Sex differences in risk factors for subclinical hypothyroidism
  Jeonghoon Ha, Jeongmin Lee, Kwanhoon Jo, Dong-Jun Lim, Moo Il Kang, Bong Yun Cha, Min-Hee Kim
  Endocrine Connections.2018; 7(4): 511.     CrossRef

Citations

Citations to this article as recorded by  

• Downhill running and caloric restriction attenuate insulin resistance associated skeletal muscle atrophy via the promotion of M2-like macrophages through TRIB3-AKT pathway
  Wei Luo, Yue Zhou, Qiang Tang, Yuhang Wang, Yansong Liu, Lei Ai
  Free Radical Biology and Medicine.2024; 210: 271.     CrossRef
• Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes
  Daniel de Luis Román, Juana Carretero Gómez, José Manuel García-Almeida, Fernando Garrachón Vallo, German Guzmán Rolo, Juan José López Gómez, Francisco José Tarazona-Santabalbina, Alejandro Sanz-Paris
  Reviews in Endocrine and Metabolic Disorders.2024;[Epub]     CrossRef
• Dynapenia and sarcopenia: association with the diagnosis, duration and complication of type 2 diabetes mellitus in ELSA-Brasil
  Débora Noara Duarte dos Santos, Carolina Gomes Coelho, Maria de Fátima Haueisen Sander Diniz, Bruce Bartholow Duncan, Maria Inês Schmidt, Isabela Judith Martins Bensenor, Claudia Szlejf, Rosa Weiss Telles, Sandhi Maria Barreto
  Cadernos de Saúde Pública.2024;[Epub]     CrossRef
• Breaking Down Cachexia: A Narrative Review on the Prevalence of Cachexia in Cancer Patients and Its Associated Risk Factors
  Mahmathi Karuppannan, Fares M. S. Muthanna, Fazlin Mohd Fauzi
  Nutrition and Cancer.2024; 76(5): 404.     CrossRef
• Mechanism of muscle atrophy in a normal-weight rat model of type 2 diabetes established by using a soft-pellet diet
  Sayaka Akieda-Asai, Hao Ma, Wanxin Han, Junko Nagata, Fumitake Yamaguchi, Yukari Date
  Scientific Reports.2024;[Epub]     CrossRef
• Morphological and functional changes in skeletal muscle in type 2 diabetes mellitus: A systematic review and meta-analysis
  Jardeson Rocha Filgueiras, Cleudiane Pereira Sales, Ivanilson Gomes da Silva, Cristiana Maria Dos Santos, Elias de Carvalho Magalhães Neto, Rebeca Barbosa da Rocha, Vinicius Saura Cardoso
  Physiotherapy Theory and Practice.2023; 39(9): 1789.     CrossRef
• Hypoglycemic drug liraglutide alleviates low muscle mass by inhibiting the expression of MuRF1 and MAFbx in diabetic muscle atrophy
  Dongmei Fan, Yue Wang, Bowei Liu, Fuzai Yin
  Journal of the Chinese Medical Association.2023; 86(2): 166.     CrossRef
• Mechanisms underlying altered neuromuscular function in people with DPN
  Antonin Le Corre, Nathan Caron, Nicolas A. Turpin, Georges Dalleau
  European Journal of Applied Physiology.2023; 123(7): 1433.     CrossRef
• Effects of body compositions on the associations between ferritin and diabetes parameters among Japanese community dwellers
  Kyi Mar Wai, Rei Akuzawa, Yoko Umeda, Wataru Munakata, Yoshiko Takahashi, Shigeyuki Nakaji, Kazushige Ihara
  Journal of Trace Elements in Medicine and Biology.2023; 78: 127174.     CrossRef
• Effects of glycemic control on frailty: a multidimensional perspective
  Ahmed H Abdelhafiz
  Hospital Practice.2023; 51(3): 124.     CrossRef
• Hand grip strength is inversely associated with total daily insulin dose requirement in patients with type 2 diabetes mellitus: a cross-sectional study
  Da-shuang Chen, Yun-qing Zhu, Wen-ji Ni, Yu-jiao Li, Guo-ping Yin, Zi-yue Shao, Jian Zhu
  PeerJ.2023; 11: e15761.     CrossRef
• Sarcopenia in Type 2 Diabetes Mellitus: Study of the Modifiable Risk Factors Involved
  Surapaneni Lakshmi Sravya, Jayshree Swain, Abhay Kumar Sahoo, Swayamsidha Mangaraj, Jayabhanu Kanwar, Pooja Jadhao, Srijit Das
  Journal of Clinical Medicine.2023; 12(17): 5499.     CrossRef
• Salbutamol ameliorates skeletal muscle wasting and inflammatory markers in streptozotocin (STZ)-induced diabetic rats
  Anand Kumar, Priyanka Prajapati, Vinit Raj, Seong-Cheol Kim, Vikas Mishra, Chaitany Jayprakash Raorane, Ritu Raj, Dinesh Kumar, Sapana Kushwaha
  International Immunopharmacology.2023; 124: 110883.     CrossRef
• Decreased serum musclin concentration is independently associated with the high prevalence of sarcopenia in Chinese middle‐elderly patients with type 2 diabetes mellitus
  Lei Fu, Qing Zhang, Juan Liu, Xiaoqing Yuan, Xinhua Ye
  Journal of Diabetes Investigation.2023; 14(12): 1412.     CrossRef
• Association between relative muscle strength and hypertension in middle-aged and older Chinese adults
  Jin-hua Luo, Tu-ming Zhang, Lin-lin Yang, Yu-ying Cai, Yu Yang
  BMC Public Health.2023;[Epub]     CrossRef
• Diabetes Mellitus in the Elderly Adults in Korea: Based on Data from the Korea National Health and Nutrition Examination Survey 2019 to 2020
  Seung-Hyun Ko, Kyung Do Han, Yong-Moon Park, Jae-Seung Yun, Kyuho Kim, Jae-Hyun Bae, Hyuk-Sang Kwon, Nan-Hee Kim
  Diabetes & Metabolism Journal.2023; 47(5): 643.     CrossRef
• Management of Hyperglycemia in Older Adults with Type 2 Diabetes
  Gunjan Y. Gandhi, Arshag D. Mooradian
  Drugs & Aging.2022; 39(1): 39.     CrossRef
• Deleterious Effect of High-Fat Diet on Skeletal Muscle Performance Is Prevented by High-Protein Intake in Adult Rats but Not in Old Rats
  Eleonora Poggiogalle, Fanny Rossignon, Aude Carayon, Fréderic Capel, Jean-Paul Rigaudière, Sarah De Saint Vincent, Olivier Le-Bacquer, Jérôme Salles, Christophe Giraudet, Véronique Patrac, Patrice Lebecque, Stéphane Walrand, Yves Boirie, Vincent Martin, C
  Frontiers in Physiology.2022;[Epub]     CrossRef
• Metabolic phenotypes explain the relationship between dysglycaemia and frailty in older people with type 2 diabetes
  A.H. Abdelhafiz, A.J. Sinclair
  Journal of Diabetes and its Complications.2022; 36(4): 108144.     CrossRef
• Altered features of body composition in older adults with type 2 diabetes and prediabetes compared with matched controls
  Kirsten E. Bell, Michael T. Paris, Egor Avrutin, Marina Mourtzakis
  Journal of Cachexia, Sarcopenia and Muscle.2022; 13(2): 1087.     CrossRef
• A modern approach to glucose-lowering therapy in frail older people with type 2 diabetes mellitus
  Ahmed H. Abdelhafiz, Daniel Pennells, Alan J. Sinclair
  Expert Review of Endocrinology & Metabolism.2022; 17(2): 95.     CrossRef
• Metabolic syndrome and its association with components of sarcopenia in older community-dwelling Chinese
  Qiangwei Tong, Xiao Wang, Yunlu Sheng, Shu Chen, Bin Lai, Rong Lv, Jing Yu
  The Journal of Biomedical Research.2022; 36(2): 120.     CrossRef
• Sarcopenia is associated with the Geriatric Nutritional Risk Index in elderly patients with poorly controlled type 2 diabetes mellitus
  Shun Matsuura, Koji Shibazaki, Reiko Uchida, Yukiko Imai, Takuya Mukoyama, Shoko Shibata, Hiroshi Morita
  Journal of Diabetes Investigation.2022; 13(8): 1366.     CrossRef
• Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
  Tsung-Hui Wu, Shiow-Chwen Tsai, Hsuan-Wei Lin, Chiao-Nan Chen, Chii-Min Hwu
  BMC Endocrine Disorders.2022;[Epub]     CrossRef
• Clinical outcomes of multidimensional association of type 2 diabetes mellitus, COVID-19 and sarcopenia: an algorithm and scoping systematic evaluation
  Anmar Al-Taie, Oritsetimeyin Arueyingho, Jalal Khoshnaw, Abdul Hafeez
  Archives of Physiology and Biochemistry.2022; : 1.     CrossRef
• Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus—a choice determined by metabolic phenotype
  Alan J. Sinclair, Daniel Pennells, Ahmed H. Abdelhafiz
  Aging Clinical and Experimental Research.2022; 34(9): 1949.     CrossRef
• Insulin in Frail, Older People with Type 2 Diabetes—Low Threshold for Therapy
  Ahmed Abdelhafiz, Shail Bisht, Iva Kovacevic, Daniel Pennells, Alan Sinclair
  Diabetology.2022; 3(2): 369.     CrossRef
• Sex-Specific Associations Between Low Muscle Mass and Glucose Fluctuations in Patients With Type 2 Diabetes Mellitus
  Xiulin Shi, Wenjuan Liu, Lulu Zhang, Fangsen Xiao, Peiying Huang, Bing Yan, Yiping Zhang, Weijuan Su, Qiuhui Jiang, Mingzhu Lin, Wei Liu, Xuejun Li
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Lifestyle factors associated with muscle quality in community‐dwelling older people with type 2 diabetes in Japan and Taiwan: a cross‐sectional study
  Yuko Yamaguchi, Chieko Greiner, Shu‐Chun Lee, Hirochika Ryuno, Hsin‐Yen Yen, Chiou‐Fen Lin, Ting‐I Lee, Pi‐Hsia Lee
  Psychogeriatrics.2022; 22(5): 736.     CrossRef
• Relationship between Echo Intensity of Vastus Lateralis and Knee Extension Strength in Patients with Type 2 Diabetes Mellitus
  Yoshikazu HIRASAWA, Ryosuke MATSUKI, Hideaki TANINA
  Physical Therapy Research.2022; 25(3): 113.     CrossRef
• Time trends (2012–2020) in glycated hemoglobin and adherence to the glycemic targets recommended for elderly patients by the Japan Diabetes Society/Japan Geriatrics Society Joint Committee among memory clinic patients with diabetes mellitus
  Taiki Sugimoto, Hisashi Noma, Yujiro Kuroda, Nanae Matsumoto, Kazuaki Uchida, Yoshinobu Kishino, Naoki Saji, Shumpei Niida, Takashi Sakurai
  Journal of Diabetes Investigation.2022; 13(12): 2038.     CrossRef
• Relationship between Diabetes Status and Sarcopenia in Community-Dwelling Older Adults
  Kazuhei Nishimoto, Takehiko Doi, Kota Tsutsumimoto, Sho Nakakubo, Satoshi Kurita, Yuto Kiuchi, Hiroyuki Shimada
  Journal of the American Medical Directors Association.2022; 23(10): 1718.e7.     CrossRef
• Low relative hand grip strength is associated with a higher risk for diabetes and impaired fasting glucose among the Korean population
  Min Jin Lee, Ah Reum Khang, Dongwon Yi, Yang Ho Kang, Giacomo Pucci
  PLOS ONE.2022; 17(10): e0275746.     CrossRef
• Association between Lower-to-Upper Ratio of Appendicular Skeletal Muscle and Metabolic Syndrome
  Hyun Eui Moon, Tae Sic Lee, Tae-Ha Chung
  Journal of Clinical Medicine.2022; 11(21): 6309.     CrossRef
• Association of plasma brain-derived neurotrophic factor levels and frailty in community-dwelling older adults
  Eun Roh, Soon Young Hwang, Eyun Song, Min Jeong Park, Hye Jin Yoo, Sei Hyun Baik, Miji Kim, Chang Won Won, Kyung Mook Choi
  Scientific Reports.2022;[Epub]     CrossRef
• Organokines, Sarcopenia, and Metabolic Repercussions: The Vicious Cycle and the Interplay with Exercise
  Giulia Minniti, Letícia Maria Pescinini-Salzedas, Guilherme Almeida dos Santos Minniti, Lucas Fornari Laurindo, Sandra Maria Barbalho, Renata Vargas Sinatora, Lance Alan Sloan, Rafael Santos de Argollo Haber, Adriano Cressoni Araújo, Karina Quesada, Jesse
  International Journal of Molecular Sciences.2022; 23(21): 13452.     CrossRef
• Multimorbidity, Frailty and Diabetes in Older People–Identifying Interrelationships and Outcomes
  Alan J. Sinclair, Ahmed H. Abdelhafiz
  Journal of Personalized Medicine.2022; 12(11): 1911.     CrossRef
• Determinants of High-Dose Insulin Usage and Upper Extremity Muscle Strength in Adult Patients With Type 2 Diabetes
  Eren Imre, Tugce Apaydin, Hatice Gizem Gunhan, Dilek Gogas Yavuz
  Canadian Journal of Diabetes.2021; 45(4): 341.     CrossRef
• Glycemic Control and Insulin Improve Muscle Mass and Gait Speed in Type 2 Diabetes: The MUSCLES-DM Study
  Ken Sugimoto, Hiroshi Ikegami, Yasunori Takata, Tomohiro Katsuya, Masahiro Fukuda, Hiroshi Akasaka, Yasuharu Tabara, Haruhiko Osawa, Yoshihisa Hiromine, Hiromi Rakugi
  Journal of the American Medical Directors Association.2021; 22(4): 834.     CrossRef
• A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors
  Anna Izzo, Elena Massimino, Gabriele Riccardi, Giuseppe Della Pepa
  Nutrients.2021; 13(1): 183.     CrossRef
• Decreased handgrip strength in patients with type 2 diabetes: A cross-sectional study in a tertiary care hospital in north India
  Parjeet Kaur, Ritesh Bansal, Bharti Bhargava, Sunil Mishra, Harmandeep Gill, Ambrish Mithal
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(1): 325.     CrossRef
• Factors associated with relative muscle strength in patients with type 2 diabetes mellitus
  Chiao-Nan Chen, Ting-Chung Chen, Shiow-Chwen Tsai, Chii-Min Hwu
  Archives of Gerontology and Geriatrics.2021; 95: 104384.     CrossRef
• Newer anti-diabetic therapies with low hypoglycemic risk-potential advantages for frail older people
  Demelza Emmerton, Ahmed Abdelhafiz
  Hospital Practice.2021; 49(3): 164.     CrossRef
• Influence of glucose, insulin fluctuation, and glycosylated hemoglobin on the outcome of sarcopenia in patients with type 2 diabetes mellitus
  Yuxi Lin, Yongze Zhang, Ximei Shen, Lingning Huang, Sunjie Yan
  Journal of Diabetes and its Complications.2021; 35(6): 107926.     CrossRef
• Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
  Gregory Habig, Christa Smaltz, Dina Halegoua-DeMarzio
  Metabolites.2021; 11(4): 242.     CrossRef
• Sensory-Motor Mechanisms Increasing Falls Risk in Diabetic Peripheral Neuropathy
  Neil D. Reeves, Giorgio Orlando, Steven J. Brown
  Medicina.2021; 57(5): 457.     CrossRef
• Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitus
  Ahmed H Abdelhafiz, Demelza Emmerton, Alan J Sinclair
  Geriatrics & Gerontology International.2021; 21(8): 614.     CrossRef
• Type 2 diabetes mellitus in older adults: clinical considerations and management
  Srikanth Bellary, Ioannis Kyrou, James E. Brown, Clifford J. Bailey
  Nature Reviews Endocrinology.2021; 17(9): 534.     CrossRef
• Metabolic Syndrome and Sarcopenia
  Hiroki Nishikawa, Akira Asai, Shinya Fukunishi, Shuhei Nishiguchi, Kazuhide Higuchi
  Nutrients.2021; 13(10): 3519.     CrossRef
• Angiotensin II inhibition: a potential treatment to slow the progression of sarcopenia
  Jeffrey Kingsley, Keiichi Torimoto, Tomoki Hashimoto, Satoru Eguchi
  Clinical Science.2021; 135(21): 2503.     CrossRef
• Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study
  Bo Kyung Koo, Seoil Moon, Min Kyong Moon
  BMC Geriatrics.2021;[Epub]     CrossRef
• Associations between homocysteine, inflammatory cytokines and sarcopenia in Chinese older adults with type 2 diabetes
  Zhi-Jing Mu, Jun-Ling Fu, Li-Na Sun, Piu Chan, Shuang-Ling Xiu
  BMC Geriatrics.2021;[Epub]     CrossRef
• The Association Between Diabetes Mellitus and Risk of Sarcopenia: Accumulated Evidences From Observational Studies
  Yu-Shun Qiao, Yin-He Chai, Hong-Jian Gong, Zhiyessova Zhuldyz, Coen D. A. Stehouwer, Jian-Bo Zhou, Rafael Simó
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• The utility of the ultrasonographic assessment of the lower leg muscles to evaluate sarcopenia and muscle quality in older adults
  Masaaki Isaka, Ken Sugimoto, Taku Fujimoto, Yukiko Yasunobe, Keyu Xie, Yuri Onishi, Shino Yoshida, Toshimasa Takahashi, Hitomi Kurinami, Hiroshi Akasaka, Yasushi Takeya, Koichi Yamamoto, Hiromi Rakugi
  JCSM Clinical Reports.2021; 6(2): 53.     CrossRef
• Associations between grip strength and glycemic control in type 2 diabetes mellitus: an analysis of data from the 2014-2019 Korea National Health and Nutrition Examination Survey
  Harim Choe, Hoyong Sung, Geon Hui Kim, On Lee, Hyo Youl Moon, Yeon Soo Kim
  Epidemiology and Health.2021; 43: e2021080.     CrossRef
• Uncontrolled Diabetes as an Associated Factor with Dynapenia in Adults Aged 50 Years or Older: Sex Differences
  Clarice Cavalero Nebuloni, Roberta de Oliveira Máximo, Cesar de Oliveira, Tiago da Silva Alexandre, Anne Newman
  The Journals of Gerontology: Series A.2020; 75(6): 1191.     CrossRef
• Identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol
  Peter Hanlon, Isabella Fauré, Neave Corcoran, Elaine Butterly, Jim Lewsey, David A McAllister, Frances S Mair
  BMJ Open.2020; 10(9): e037476.     CrossRef
• Longitudinal association of type 2 diabetes and insulin therapy with muscle parameters in the KORA-Age study
  Uta Ferrari, Cornelia Then, Marietta Rottenkolber, Canan Selte, Jochen Seissler, Romy Conzade, Birgit Linkohr, Annette Peters, Michael Drey, Barbara Thorand
  Acta Diabetologica.2020; 57(9): 1057.     CrossRef
• Triad of impairment in older people with diabetes-reciprocal relations and clinical implications
  A.H. Abdelhafiz, P.C. Davies, A.J. Sinclair
  Diabetes Research and Clinical Practice.2020; 161: 108065.     CrossRef
• Physical activity and exercise: Strategies to manage frailty
  Javier Angulo, Mariam El Assar, Alejandro Álvarez-Bustos, Leocadio Rodríguez-Mañas
  Redox Biology.2020; 35: 101513.     CrossRef
• Handgrip measurement as a useful benchmark for locomotive syndrome in patients with type 2 diabetes mellitus: A KAMOGAWA‐DM cohort study
  Noriyuki Kitagawa, Takuro Okamura, Nobuko Kitagawa, Yoshitaka Hashimoto, Masahide Hamaguchi, Michiaki Fukui
  Journal of Diabetes Investigation.2020; 11(6): 1602.     CrossRef
• Edmonton frail score is associated with diabetic control in elderly type 2 diabetic subjects
  Satilmis Bilgin, Gulali Aktas, Ozge Kurtkulagi, Burcin M. Atak, Tuba T. Duman
  Journal of Diabetes & Metabolic Disorders.2020; 19(1): 511.     CrossRef
• Comparison of field- and laboratory-based estimates of muscle quality index between octogenarians and young older adults: an observational study
  Dahan da Cunha Nascimento, Jonato Prestes, Joyce de Sousa Diniz, Pedro Rodrigues Beal, Vicente Paulo Alves, Whitley Stone, Fabiani Lage Rodrigues Beal
  Journal of Exercise Rehabilitation.2020; 16(5): 458.     CrossRef
• Tip 2 Diyabetli Hastalarda Kan Glukoz Seviyesi ile Kas Gücü, Propriosepsiyon ve Vücut Kompozisyonu Arasındaki İlişki
  Zahide Betül TAYFUR, Esra ATILGAN
  Turkish Journal of Diabetes and Obesity.2020; 4(3): 207.     CrossRef
• Challenges and Strategies for Diabetes Management in Community-Living Older Adults
  Alan J. Sinclair, Ahmed H. Abdelhafiz
  Diabetes Spectrum.2020; 33(3): 217.     CrossRef
• Association between deterioration in muscle strength and peripheral neuropathy in people with diabetes
  Tae Jung Oh, Sunyoung Kang, Jie-Eun Lee, Jae Hoon Moon, Sung Hee Choi, Soo Lim, Hak Chul Jang
  Journal of Diabetes and its Complications.2019; 33(8): 598.     CrossRef
• The Association between Body Composition using Dual energy X-ray Absorptiometry and Type-2 Diabetes: A Systematic Review and Meta-Analysis of Observational studies
  Preeti Gupta, Carla Lanca, Alfred T. L. Gan, Pauline Soh, Sahil Thakur, Yijin Tao, Neelam Kumari, Ryan E. K. Man, Eva K. Fenwick, Ecosse L. Lamoureux
  Scientific Reports.2019;[Epub]     CrossRef
• MECHANISMS OF ENDOCRINE DISEASE: Sarcopenia in endocrine and non-endocrine disorders
  Victoria Zeghbi Cochenski Borba, Tatiana Lemos Costa, Carolina Aguiar Moreira, Cesar Luiz Boguszewski
  European Journal of Endocrinology.2019; 180(5): R185.     CrossRef
• Hyperglycemia induces skeletal muscle atrophy via a WWP1/KLF15 axis
  Yu Hirata, Kazuhiro Nomura, Yoko Senga, Yuko Okada, Kenta Kobayashi, Shiki Okamoto, Yasuhiko Minokoshi, Michihiro Imamura, Shin’ichi Takeda, Tetsuya Hosooka, Wataru Ogawa
  JCI Insight.2019;[Epub]     CrossRef
• Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus
  Ken Sugimoto, Yasuharu Tabara, Hiroshi Ikegami, Yasunori Takata, Kei Kamide, Tome Ikezoe, Eri Kiyoshige, Yukako Makutani, Hiroshi Onuma, Yasuyuki Gondo, Kazunori Ikebe, Noriaki Ichihashi, Tadao Tsuboyama, Fumihiko Matsuda, Katsuhiko Kohara, Mai Kabayama,
  Journal of Diabetes Investigation.2019; 10(6): 1471.     CrossRef
• Diabetic Peripheral Neuropathy as a Risk Factor for Sarcopenia
  Tae Jung Oh, Yoojung Song, Jae Hoon Moon, Sung Hee Choi, Hak Chul Jang
  Annals of Geriatric Medicine and Research.2019; 23(4): 170.     CrossRef
• Diabetes and frailty
  Mariam El Assar, Olga Laosa, Leocadio Rodríguez Mañas
  Current Opinion in Clinical Nutrition & Metabolic Care.2019; 22(1): 52.     CrossRef
• Association of Glucose Fluctuations with Sarcopenia in Older Adults with Type 2 Diabetes Mellitus
  Noriko Ogama, Takashi Sakurai, Shuji Kawashima, Takahisa Tanikawa, Haruhiko Tokuda, Shosuke Satake, Hisayuki Miura, Atsuya Shimizu, Manabu Kokubo, Shumpei Niida, Kenji Toba, Hiroyuki Umegaki, Masafumi Kuzuya
  Journal of Clinical Medicine.2019; 8(3): 319.     CrossRef
• Diabetes in the elderly
  Ahmed H. Abdelhafiz, Alan J. Sinclair
  Medicine.2019; 47(2): 119.     CrossRef
• Diabetes and Muscle Dysfunction in Older Adults
  Hak Chul Jang
  Annals of Geriatric Medicine and Research.2019; 23(4): 160.     CrossRef
• Factors influencing safe glucose-lowering in older adults with type 2 diabetes: A PeRsOn-centred ApproaCh To IndiVidualisEd (PROACTIVE) Glycemic Goals for older people
  C.E. Hambling, K. Khunti, X. Cos, J. Wens, L. Martinez, P. Topsever, S. Del Prato, A. Sinclair, G. Schernthaner, G. Rutten, S. Seidu
  Primary Care Diabetes.2019; 13(4): 330.     CrossRef
• Effects of resistance training on neuromuscular parameters in elderly with type 2 diabetes mellitus: A randomized clinical trial
  Cíntia E. Botton, Daniel Umpierre, Anderson Rech, Lucinéia O. Pfeifer, Carlos L.F. Machado, Juliana L. Teodoro, Alexandre S. Dias, Ronei S. Pinto
  Experimental Gerontology.2018; 113: 141.     CrossRef
• Management of Elderly Diabetes Patients Who Are Unable to Self-Care
  Bok Rye Song
  The Journal of Korean Diabetes.2018; 19(4): 232.     CrossRef
• Decreased Muscle Strength and Quality in Diabetes-Related Dementia
  Akito Tsugawa, Yusuke Ogawa, Naoto Takenoshita, Yoshitsugu Kaneko, Hirokuni Hatanaka, Eriko Jaime, Raita Fukasawa, Haruo Hanyu
  Dementia and Geriatric Cognitive Disorders Extra.2017; 7(3): 454.     CrossRef
• Diabetes and Sarcopenia
  Dong Hyun Kim, Tae Yang Yu
  The Journal of Korean Diabetes.2017; 18(4): 239.     CrossRef
• Frailty and sarcopenia - newly emerging and high impact complications of diabetes
  Alan J. Sinclair, Ahmed H. Abdelhafiz, Leocadio Rodríguez-Mañas
  Journal of Diabetes and its Complications.2017; 31(9): 1465.     CrossRef
• Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: a cross-sectional study
  Tatsuya Fukuda, Ryotaro Bouchi, Takato Takeuchi, Yujiro Nakano, Masanori Murakami, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto, Yoshihiro Ogawa
  BMJ Open Diabetes Research & Care.2017; 5(1): e000404.     CrossRef
• Practical considerations for managing patients with diabetes and dementia
  Michelle L Mair, Rohin Athavale, Ahmed H Abdelhafiz
  Expert Review of Endocrinology & Metabolism.2017; 12(6): 429.     CrossRef
• Sarcopenia: An Endocrine Disorder?
  Alexis McKee, John E. Morley, Alvin M. Matsumoto, Aaron Vinik
  Endocrine Practice.2017; 23(9): 1143.     CrossRef
• Response: Hyperglycemia Is Associated with Impaired Muscle Quality in Older Men with Diabetes: The Korean Longitudinal Study on Health and Aging (Diabetes Metab J 2016;40:140-6)
  Ji Won Yoon, Hak Chul Jang
  Diabetes & Metabolism Journal.2016; 40(3): 250.     CrossRef
• Salivary lactate dehydrogenase and aminotransferases in diabetic patients
  Barbara Malicka, Katarzyna Skoskiewicz-Malinowska, Urszula Kaczmarek
  Medicine.2016; 95(47): e5211.     CrossRef
• Explanatory models of muscle performance in acromegaly patients evaluated by knee isokinetic dynamometry: Implications for rehabilitation
  Agnaldo José Lopes, Arthur Sá Ferreira, Evelyn Mendes Walchan, Mauricio Santos Soares, Priscila Santos Bunn, Fernando Silva Guimarães
  Human Movement Science.2016; 49: 160.     CrossRef
• Letter: Hyperglycemia Is Associated with Impaired Muscle Quality in Older Men with Diabetes: The Korean Longitudinal Study on Health and Aging (Diabetes Metab J 2016;40:140-6)
  Jun Sung Moon
  Diabetes & Metabolism Journal.2016; 40(3): 248.     CrossRef
• Sarcopenia, Frailty, and Diabetes in Older Adults
  Hak Chul Jang
  Diabetes & Metabolism Journal.2016; 40(3): 182.     CrossRef

The goal for the treatment of patients with diabetes has today shifted from merely reducing glucose concentrations to preventing the natural decline in β-cell function and delay the progression of disease. Pancreatic β-cell dysfunction and decreased β-cell mass are crucial in the development of diabetes. The β-cell defects are the main pathogenesis in patients with type 1 diabetes and are associated with type 2 diabetes as the disease progresses. Recent studies suggest that human pancreatic β-cells have a capacity for increased proliferation according to increased demands for insulin. In humans, β-cell mass has been shown to increase in patients showing insulin-resistance states such as obesity or in pregnancy. This capacity might be useful for identifying new therapeutic strategies to reestablish a functional β-cell mass. In this context, therapeutic approaches designed to increase β-cell mass might prove a significant way to manage diabetes and prevent its progression. This review describes the various β-cell defects that appear in patients with diabetes and outline the mechanisms of β-cell failure. We also review common methods for assessing β-cell function and mass and methodological limitations in vivo. Finally, we discuss the current therapeutic approaches to improve β-cell function and increase β-cell mass.

Citations

Citations to this article as recorded by  

• Polychlorinated biphenyls exposure and type 2 diabetes: Molecular mechanism that causes insulin resistance and islet damage
  Qiuli Shan, Jingyu Liu, Fan Qu, Anhui Chen, Wenxing He
  Environmental Toxicology.2024; 39(4): 2466.     CrossRef
• Beta‐cell function in type 2 diabetes (T2DM): Can it be preserved or enhanced?
  Laure Sayyed Kassem, Aman Rajpal, Margarita Victoria Barreiro, Faramarz Ismail‐Beigi
  Journal of Diabetes.2023; 15(10): 817.     CrossRef
• Preliminary Evaluation of Potential Properties of Three Probiotics and Their Combination with Prebiotics on GLP-1 Secretion and Type 2 Diabetes Alleviation
  Ran Xiao, Ran Wang, Shusen Li, Xiaohong Kang, Yimei Ren, Erna Sun, Chenyuan Wang, Jingjing He, Jing Zhan, Wen Yi Kang
  Journal of Food Quality.2022; 2022: 1.     CrossRef
• Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using 111In-exendin-4 SPECT/CT imaging and the perspective of mitochondrial involvements
  Muhammad Fauzi, Takaaki Murakami, Hiroyuki Fujimoto, Ainur Botagarova, Kentaro Sakaki, Sakura Kiyobayashi, Masahito Ogura, Nobuya Inagaki
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1
  Lie-Chwen Lin, Lin-Chien Lee, Cheng Huang, Chiung-Tong Chen, Jen-Shin Song, Young-Ji Shiao, Hui-Kang Liu
  Phytomedicine.2019; 62: 152946.     CrossRef
• The Potential of Hibiscus sabdariffa Linn in Inducing Glucagon-Like Peptide-1 via SGLT-1 and GLPR in DM Rats
  Neng Tine Kartinah, Fadilah Fadilah, Ermita Ilyas Ibrahim, Yuliana Suryati
  BioMed Research International.2019; 2019: 1.     CrossRef
• Efficacy of short‑term intensive treatment with insulin pump to improve islet β‑cell function in newly diagnosed type 2 diabetes via inhibition of oxidative stress
  Hai‑Tong Liu, Yan Gao
  Experimental and Therapeutic Medicine.2019;[Epub]     CrossRef
• When metformin is not enough: Pros and cons of SGLT2 and DPP‐4 inhibitors as a second line therapy
  Angelo Avogaro, Elías Delgado, Ildiko Lingvay
  Diabetes/Metabolism Research and Reviews.2018;[Epub]     CrossRef
• Metformin prevents glucotoxicity by alleviating oxidative and ER stress–induced CD36 expression in pancreatic beta cells
  Jun Sung Moon, Udayakumar Karunakaran, Suma Elumalai, In-Kyu Lee, Hyoung Woo Lee, Yong-Woon Kim, Kyu Chang Won
  Journal of Diabetes and its Complications.2017; 31(1): 21.     CrossRef
• The variability in beta‐cell function in placebo‐treated subjects with type 2 diabetes: application of the weight‐HbA1c‐insulin‐glucose (WHIG) model
  Janna K. Duong, Willem de Winter, Steve Choy, Nele Plock, Himanshu Naik, Walter Krauwinkel, Sandra A.G. Visser, Katia M. Verhamme, Miriam C. Sturkenboom, B.H. Stricker, Meindert Danhof
  British Journal of Clinical Pharmacology.2017; 83(3): 487.     CrossRef
• Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling
  Bethany A. Carboneau, Richard M. Breyer, Maureen Gannon
  Journal of Cell Communication and Signaling.2017; 11(2): 105.     CrossRef
• Effects of low intensity laser acupoint irradiation on inhibiting islet beta-cell apoptosis in rats with type 2 diabetes
  Guoxin Xiong, Leilei Xiong, Xinzhong Li
  Laser Physics.2016; 26(9): 095605.     CrossRef
• Effects of continuous positive airway pressure treatment on glucose metabolism in patients with obstructive sleep apnea
  Elisabet Martínez-Ceron, Isabel Fernández-Navarro, Francisco Garcia-Rio
  Sleep Medicine Reviews.2016; 25: 121.     CrossRef
• Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase‐4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24‐week multicentre, randomized, double‐blind, placebo‐controlled phase III trial
  S. Hong, C.‐Y. Park, K. A. Han, C. H. Chung, B. J. Ku, H. C. Jang, C. W. Ahn, M.‐K. Lee, M. K. Moon, H. S. Son, C. B. Lee, Y.‐W. Cho, S.‐W. Park
  Diabetes, Obesity and Metabolism.2016; 18(5): 528.     CrossRef
• Senp2 expression was induced by chronic glucose stimulation in INS1 cells, and it was required for the associated induction of Ccnd1 and Mafa
  Hye Seung Jung, Yu Mi Kang, Ho Seon Park, Byung Yong Ahn, Hakmo Lee, Min Joo Kim, Jin Young Jang, Sun-Whe Kim
  Islets.2016; 8(6): 207.     CrossRef
• ANTIDIABETIC EVALUATION OF CHONEMORPHA MACROPHYLLA ROOTS BY IN VIVO METHODS USING MALE WISTAR ALBINO RATS AND ITS MECHANISM OF ACTION
  K. R. Krishna Kumar, K. K. Srinivasan
  INDIAN DRUGS.2016; 53(12): 42.     CrossRef
• Comparative gene expression profiles in pancreatic islets associated with agouti yellow mutation and PACAP overexpression in mice
  Kazuya Ikeda, Shuhei Tomimoto, Soken Tsuchiya, Ken-ichi Hamagami, Norihito Shintani, Yukihiko Sugimoto, Atsushi Ichikawa, Atsushi Kasai, Takanobu Nakazawa, Kazuki Nagayasu, Atsuko Hayata-Takano, Akemichi Baba, Hitoshi Hashimoto
  Biochemistry and Biophysics Reports.2015; 2: 179.     CrossRef
• Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes
  LI-XUE GUAN, HUI GUAN, HAI-BO LI, CUI-AI REN, LIN LIU, JIN-JIN CHU, LONG-JUN DAI
  Experimental and Therapeutic Medicine.2015; 9(5): 1623.     CrossRef
• p13 overexpression in pancreatic β-cells ameliorates type 2 diabetes in high-fat-fed mice
  Shintaro Higashi, Kazuhiko Katagi, Norihito Shintani, Kazuya Ikeda, Yukihiko Sugimoto, Soken Tsuchiya, Naoki Inoue, Shota Tanaka, Mai Koumoto, Atsushi Kasai, Takanobu Nakazawa, Atsuko Hayata-Takano, Ken-Ichi Hamagami, Shuhei Tomimoto, Takuya Yoshida, Tada
  Biochemical and Biophysical Research Communications.2015; 461(4): 612.     CrossRef